Revision as of 07:38, 21 December 2010 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - updated 'UNII_Ref', 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref') per Chem/Drugbox validation (report [[Misplaced Pages talk:WikiProject_Pharmacology|← Previous edit | Revision as of 01:37, 30 January 2011 edit undoNmatavka (talk | contribs)1,040 editsNo edit summaryNext edit → | ||
Line 43: | Line 43: | ||
<references /> | <references /> | ||
] | |||
] | |||
] | ] | ||
] | ] |
Revision as of 01:37, 30 January 2011
Pharmaceutical compoundClinical data | |
---|---|
Other names | β-Methylfentanyl |
ATC code |
|
Identifiers | |
IUPAC name
| |
PubChem CID | |
ChemSpider | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C23H30N2O |
Molar mass | 350.497 g/mol g·mol |
3D model (JSmol) | |
SMILES
| |
(verify) |
β-Methylfentanyl is an opioid analgesic that is an analogue of fentanyl.
β-Methylfentanyl was sold briefly on the black market in the early 1980s, before the introduction of the Federal Analog Act which for the first time attempted to control entire families of drugs based on their structural similarity rather than scheduling each drug individually as they appeared.
β-Methylfentanyl has similar effects to fentanyl. Side effects of fentanyl analogues are similar to those of fentanyl itself, which include itching, nausea, and respiratory depression, which can be serious and even life-threatening.
References
- Henderson GL. Designer Drugs: Past History and Future Prospects. Journal of Forensic Sciences 1988; 33(2):569-575